Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing

Steroids

Volumn 75, Issue 3, 2010, Pages 282-286

  Weber, Agnes J ^a,b   Li, Gang ^a,c   Kalak, Robert ^a   Street, Janine ^a   Buttgereit, Frank ^b   Dunstan, Colin R ^a,d   Seibel, Markus J ^a   Zhou, Hong ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d Biomedical Engineering   (Australia)

Author keywords

Glucocorticoids; Hydroxysteroid dehydrogenase (HSD); Intramembranous bone healing; Osteoblast

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; COLLAGEN TYPE 1; GLUCOCORTICOID;

ANALYTICAL PARAMETERS; ARTICLE; BONE DEFECT; BONE DENSITY; CELL DISRUPTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORTICAL BONE; FRACTURE NONUNION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRANSGENICS; WILD TYPE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; ANIMALS; CALCIFICATION, PHYSIOLOGIC; COLLAGEN TYPE I; FRACTURE HEALING; GLUCOCORTICOIDS; HUMANS; MALE; MICE; MICE, TRANSGENIC; OSTEOBLASTS; SIGNAL TRANSDUCTION; TIBIA; TRANSGENES; X-RAY MICROTOMOGRAPHY;

ANIMALIA; MUS MUSCULUS;

EID: 76349125975     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.01.005     Document Type: Article

References (21)

1. Canalis E., Mazziotti G., Giustina A., and Bilezikian J.P. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18 (2007) 1319-1328
2. Aspenberg P. Drugs and fracture repair. Acta Orthop 76 (2005) 741-748
3. Eijken M., Koedam M., van Driel M., Buurman C.J., Pols H.A., and van Leeuwen J.P. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol 248 (2006) 87-93
4. Bellows C.G., Aubin J.E., and Heersche J.N. Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121 (1987) 1985-1992
5. Cheng S.L., Yang J.W., Rifas L., Zhang S.F., and Avioli L.V. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134 (1994) 277-286
6. Zhou H., Mak W., Zheng Y., Dunstan C.R., and Seibel M.J. Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. J Biol Chem 283 (2008) 1936-1945
7. Zhou H., Mak W., Kalak R., Street J., Fong-Yee C., Zheng Y., et al. Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Development 136 (2009) 427-436
8. Kalajzic I., Kalajzic Z., Kaliterna M., Gronowicz G., Clark S.H., Lichtler A.C., et al. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res 17 (2002) 15-25
9. Sher L.B., Woitge H.W., Adams D.J., Gronowicz G.A., Krozowski Z., Harrison J.R., et al. Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology 145 (2004) 922-929
10. Zheng Y., Zhou H., Modzelewski J.R.K., Kalak R., Blair J.M., Seibel M.J., et al. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res 67 (2007) 9542-9548
11. Kalak R., Zhou H., Street J., Day R.E., Modzelewski J.R.K., Spies C.M., et al. Endogenous glucocorticoid signaling in osteoblasts is necessary to maintain normal bone structure in mice. Bone 45 (2009) 61-67
12. Smith R.E., Li K.X., Andrews R.K., and Krozowski Z. Immunohistochemical and molecular characterization of the rat 11 beta-hydroxysteroid dehydrogenase type II enzyme. Endocrinology 138 (1997) 540-547
13. Odermatt A., Arnold P., Stauffer A., Frey B.M., and Frey F.J. The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane. J Biol Chem 274 (1999) 28762-28770
14. Stewart P.M., and Krozowski Z.S. 11 beta-hydroxysteroid dehydrogenase. Vitam Horm 57 (1999) 249-324
15. Woitge H., Harrison J., Ivkosic A., Krozowski Z., and Kream B. Cloning and in vitro characterization of alpha 1(I)-collagen 11 beta-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids. Endocrinology 142 (2001) 1341-1348
16. Kim J.-B., Leucht P., Lam K., Luppen C., Ten Berge D., Nusse R., et al. Bone regeneration is regulated by Wnt signaling. J Bone Miner Res 22 (2007) 1913-1923
17. Street J., Bao M., deGuzman L., Bunting S., Peale Jr. F.V., Ferrara N., et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci 99 (2002) 9656-9661
18. Campbell T.M., Wong W.T., and Mackie E.J. Establishment of a model of cortical bone repair in mice. Calcif Tissue Int 73 (2003) 49-55
19. Li G., Bunn J.R., Mushipe M.T., He Q., and Chen X. Effects of pleiotrophin (PTN) over-expression on mouse long bone development, fracture healing and bone repair. Calcif Tissue Int 76 (2005) 299-306
20. Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15 (2008) 53-76
21. de Crombrugghe B., Lefebvre V., and Nakashima K. Regulatory mechanisms in the pathways of cartilage and bone formation. Curr Opin Cell Biol 13 (2001) 721-727